A detailed history of Engineers Gate Manager LP transactions in Silk Road Medical Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 14,010 shares of SILK stock, worth $378,550. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,010
Previous 196,835 92.88%
Holding current value
$378,550
Previous $2.42 Million 89.4%
% of portfolio
0.01%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$11.38 - $19.03 $2.08 Million - $3.48 Million
-182,825 Reduced 92.88%
14,010 $256,000
Q4 2023

Feb 14, 2024

BUY
$6.29 - $15.72 $260,751 - $651,672
41,455 Added 26.68%
196,835 $2.42 Million
Q3 2023

Nov 14, 2023

BUY
$14.99 - $32.65 $477,611 - $1.04 Million
31,862 Added 25.8%
155,380 $2.33 Million
Q2 2023

Aug 14, 2023

SELL
$29.76 - $46.14 $445,358 - $690,485
-14,965 Reduced 10.81%
123,518 $4.01 Million
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $4.06 Million - $6.15 Million
106,505 Added 333.06%
138,483 $5.42 Million
Q4 2022

Feb 14, 2023

BUY
$40.54 - $56.2 $957,027 - $1.33 Million
23,607 Added 282.01%
31,978 $1.69 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $309,559 - $411,853
8,371 New
8,371 $377,000
Q4 2021

Feb 14, 2022

SELL
$39.32 - $61.61 $211,934 - $332,077
-5,390 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$44.0 - $65.8 $237,160 - $354,662
5,390 New
5,390 $297,000
Q1 2021

May 17, 2021

SELL
$46.31 - $62.7 $470,880 - $637,533
-10,168 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$55.51 - $69.94 $564,425 - $711,149
10,168 New
10,168 $640,000
Q2 2020

Aug 17, 2020

SELL
$27.55 - $43.28 $495,624 - $778,607
-17,990 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$23.16 - $47.8 $416,648 - $859,922
17,990 New
17,990 $566,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.02B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.